Other Species / Isoforms
  CK1D (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S53-p
HPQLHIEskIYkMMQ
Upstream
1 0
Kinase, in vitro:
  • PKCA (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • Go_6983
CK1D (human) HPQLHIEskIYkMMQ S53-p
CK1D iso2 (human) HPQLHIESKIYKMMQ S53
CK1D (mouse) HPQLHIESKIYkMMQ S53
CK1D iso2 (mouse) HPQLHIESKIYKMMQ S53
CK1D (rat) HPQLHIESKIYKMMQ S53
K54-ub
PQLHIEskIYkMMQG
0 1
CK1D (human) PQLHIEskIYkMMQG K54-ub
CK1D iso2 (human) PQLHIESKIYKMMQG K54
CK1D (mouse) PQLHIESKIYkMMQG K54
CK1D iso2 (mouse) PQLHIESKIYKMMQG K54
CK1D (rat) PQLHIESKIYKMMQG K54
K57-ub
HIEskIYkMMQGGVG
0 3
CK1D (human) HIEskIYkMMQGGVG K57-ub
CK1D iso2 (human) HIESKIYKMMQGGVG K57
CK1D (mouse) HIESKIYkMMQGGVG K57-ub
CK1D iso2 (mouse) HIESKIYKMMQGGVG K57
CK1D (rat) HIESKIYKMMQGGVG K57
K140-ub
NFLMGLGkKGNLVYI
0 3
CK1D (human) NFLMGLGkKGNLVYI K140-ub
CK1D iso2 (human) NFLMGLGKKGNLVYI K140
CK1D (mouse) NFLMGLGkKGNLVYI K140-ub
CK1D iso2 (mouse) NFLMGLGKKGNLVYI K140
CK1D (rat) NFLMGLGKKGNLVYI K140
T161-p
KKYRDARtHQHIPYR
Upstream
1 1
Kinase, in vitro:
  • PKCA (human)
CK1D (human) KKYRDARtHQHIPYR T161-p
CK1D iso2 (human) under review -
CK1D (mouse) under review -
CK1D iso2 (mouse) under review -
CK1D (rat) under review -
T174-p
YRENKNLtGtARYAs
Upstream
1 1
Kinase, in vitro:
  • PKCA (human)
CK1D (human) YRENKNLtGtARYAs T174-p
CK1D iso2 (human) under review -
CK1D (mouse) under review -
CK1D iso2 (mouse) under review -
CK1D (rat) under review -
T176-p
ENKNLtGtARYAsIN
Upstream
Downstream
1 1
Effects on Modified Protein
  • enzymatic activity, induced
Kinase, in vitro:
  • PKCA (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • Go_6983
CK1D (human) ENKNLtGtARYAsIN T176-p
CK1D iso2 (human) ENKNLTGTARYASIN T176
CK1D (mouse) ENKNLTGTARYASIN T176
CK1D iso2 (mouse) ENKNLTGTARYASIN T176
CK1D (rat) ENKNLTGTARYASIN T176
S181-p
tGtARYAsINTHLGI
Upstream
1 1
Kinase, in vitro:
  • PKCA (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • Go_6983
CK1D (human) tGtARYAsINTHLGI S181-p
CK1D iso2 (human) TGTARYASINTHLGI S181
CK1D (mouse) TGTARYASINTHLGI S181
CK1D iso2 (mouse) TGTARYASINTHLGI S181
CK1D (rat) TGTARYASINTHLGI S181
S191-p
THLGIEQsRRDDLES
Upstream
1 1
Kinase, in vitro:
  • PKCA (human)
CK1D (human) THLGIEQsRRDDLES S191-p
CK1D iso2 (human) under review -
CK1D (mouse) under review -
CK1D iso2 (mouse) under review -
CK1D (rat) under review -
K242-ac
TPIEVLCkGYPSEFA
0 1
CK1D (human) TPIEVLCkGYPSEFA K242-ac
CK1D iso2 (human) TPIEVLCKGYPSEFA K242
CK1D (mouse) TPIEVLCKGYPSEFA K242
CK1D iso2 (mouse) TPIEVLCKGYPSEFA K242
CK1D (rat) TPIEVLCKGYPSEFA K242
K263-ub
RSLRFDDkPDySYLR
0 3
CK1D (human) RSLRFDDkPDySYLR K263-ub
CK1D iso2 (human) RSLRFDDKPDYSYLR K263
CK1D (mouse) RSLRFDDkPDYSYLR K263-ub
CK1D iso2 (mouse) RSLRFDDKPDYSYLR K263
CK1D (rat) RSLRFDDKPDYSYLR K263
Y266-p
RFDDkPDySYLRQLF
0 1
CK1D (human) RFDDkPDySYLRQLF Y266-p
CK1D iso2 (human) RFDDKPDYSYLRQLF Y266
CK1D (mouse) RFDDkPDYSYLRQLF Y266
CK1D iso2 (mouse) RFDDKPDYSYLRQLF Y266
CK1D (rat) RFDDKPDYSYLRQLF Y266
S298-p
NMLKFGAsRAADDAE
Upstream
1 1
Kinase, in vitro:
  • PKCA (human)
CK1D (human) NMLKFGAsRAADDAE S298-p
CK1D iso2 (human) under review -
CK1D (mouse) under review -
CK1D iso2 (mouse) under review -
CK1D (rat) under review -
S318
REERLRHSRNPATRG
0 1
CK1D (human) REERLRHSRNPATRG S318
CK1D iso2 (human) REERLRHSRNPATRG S318
CK1D (mouse) REERLRHSRNPATRG S318
CK1D iso2 (mouse) REERLRHSRNPATRG S318
CK1D (rat) REERLRHsRNPATRG S318-p
S328-p
PATRGLPstAsGRLr
Upstream
2 14
Treatment
  • MG132_withdrawal
CK1D (human) PATRGLPstAsGRLr S328-p
CK1D iso2 (human) PATRGLPSTASGRLR S328
CK1D (mouse) PATRGLPsTAsGRLR S328-p
CK1D iso2 (mouse) PATRGLPSTASGRLR S328
CK1D (rat) PATRGLPstAsGRLR S328-p
T329-p
ATRGLPstAsGRLrG
1 2
CK1D (human) ATRGLPstAsGRLrG T329-p
CK1D iso2 (human) ATRGLPSTASGRLRG T329
CK1D (mouse) ATRGLPsTAsGRLRG T329
CK1D iso2 (mouse) ATRGLPSTASGRLRG T329
CK1D (rat) ATRGLPstAsGRLRG T329-p
S331-p
RGLPstAsGRLrGtQ
Upstream
1 32
Treatment
  • MG132_withdrawal
CK1D (human) RGLPstAsGRLrGtQ S331-p
CK1D iso2 (human) RGLPSTASGRLRGTQ S331
CK1D (mouse) RGLPsTAsGRLRGTQ S331-p
CK1D iso2 (mouse) RGLPSTASGRLRGTQ S331
CK1D (rat) RGLPstAsGRLRGTQ S331-p
R335-m1
stAsGRLrGtQEVAP
0 1
CK1D (human) stAsGRLrGtQEVAP R335-m1
CK1D iso2 (human) STASGRLRGTQEVAP R335
CK1D (mouse) sTAsGRLRGTQEVAP R335
CK1D iso2 (mouse) STASGRLRGTQEVAP R335
CK1D (rat) stAsGRLRGTQEVAP R335
T337-p
AsGRLrGtQEVAPPt
0 1
CK1D (human) AsGRLrGtQEVAPPt T337-p
CK1D iso2 (human) ASGRLRGTQEVAPPT T337
CK1D (mouse) AsGRLRGTQEVAPPt T337
CK1D iso2 (mouse) ASGRLRGTQEVAPPT T337
CK1D (rat) AsGRLRGTQEVAPPT T337
T344-p
tQEVAPPtPLtPtsH
0 7
CK1D (human) tQEVAPPtPLtPtsH T344-p
CK1D iso2 (human) TQEVAPPTPLTPTSH T344
CK1D (mouse) TQEVAPPtPLtPTSH T344-p
CK1D iso2 (mouse) TQEVAPPTPLTPTSH T344
CK1D (rat) TQEVAPPTPLTPTSH T344
T347-p
VAPPtPLtPtsHTAN
Upstream
Downstream
1 18
Effects on Modified Protein
  • enzymatic activity, induced
Treatment
  • calyculin_A
  • nocodazole
  • staurosporine
  • thymidine
CK1D (human) VAPPtPLtPtsHTAN T347-p
CK1D iso2 (human) VAPPTPLTPTSHTAN T347
CK1D (mouse) VAPPtPLtPTSHtAN T347-p
CK1D iso2 (mouse) VAPPTPLTPTSHTAN T347
CK1D (rat) VAPPTPLTPTSHTAN T347
T349-p
PPtPLtPtsHTANts
0 3
CK1D (human) PPtPLtPtsHTANts T349-p
CK1D iso2 (human) PPTPLTPTSHTANTS T349
CK1D (mouse) PPtPLtPTSHtANTs T349
CK1D iso2 (mouse) PPTPLTPTSHTANTS T349
CK1D (rat) PPTPLTPTSHTANTS T349
S350-p
PtPLtPtsHTANtsP
0 3
CK1D (human) PtPLtPtsHTANtsP S350-p
CK1D iso2 (human) PTPLTPTSHTANTSP S350
CK1D (mouse) PtPLtPTSHtANTsP S350
CK1D iso2 (mouse) PTPLTPTSHTANTSP S350
CK1D (rat) PTPLTPTSHTANTSP S350
T352
PLtPtsHTANtsPRP
0 1
CK1D (human) PLtPtsHTANtsPRP T352
CK1D iso2 (human) PLTPTSHTANTSPRP T352
CK1D (mouse) PLtPTSHtANTsPRP T352-p
CK1D iso2 (mouse) PLTPTSHTANTSPRP T352
CK1D (rat) PLTPTSHTANTSPRP T352
T355-p
PtsHTANtsPRPVsG
Upstream
0 3
Treatment
  • nocodazole
  • thymidine
CK1D (human) PtsHTANtsPRPVsG T355-p
CK1D iso2 (human) PTSHTANTSPRPVSG T355
CK1D (mouse) PTSHtANTsPRPVsG T355
CK1D iso2 (mouse) PTSHTANTSPRPVSG T355
CK1D (rat) PTSHTANTSPRPVSG T355
S356-p
tsHTANtsPRPVsGM
Upstream
0 8
Treatment
  • MG132_withdrawal
  • nocodazole
  • thymidine
CK1D (human) tsHTANtsPRPVsGM S356-p
CK1D iso2 (human) TSHTANTSPRPVSGM S356
CK1D (mouse) TSHtANTsPRPVsGM S356-p
CK1D iso2 (mouse) TSHTANTSPRPVSGM S356
CK1D (rat) TSHTANTSPRPVSGM S356
S361-p
NtsPRPVsGMERERK
Upstream
0 4
Treatment
  • vemurafenib
CK1D (human) NtsPRPVsGMERERK S361-p
CK1D iso2 (human) NTSPRPVSGMERERK S361
CK1D (mouse) NTsPRPVsGMERERK S361-p
CK1D iso2 (mouse) NTSPRPVSGMERERK S361
CK1D (rat) NTSPRPVSGMERERK S361
S370
MERERKVSMRLHrGA
3 2
CK1D (human) MERERKVSMRLHrGA S370
CK1D iso2 (human) MERERKVSMRLHRGA S370
CK1D (mouse) MERERKVSMRLHrGA S370
CK1D iso2 (mouse) MERERKVSMRLHRGA S370
CK1D (rat) MERERKVsMRLHRGA S370-p
R375-m1
KVSMRLHrGAPVNIs
0 6
CK1D (human) KVSMRLHrGAPVNIs R375-m1
CK1D iso2 (human) KVSMRLHRGAPVNIS R375
CK1D (mouse) KVSMRLHrGAPVNVs R375-m1
CK1D iso2 (mouse) KVSMRLHRGAPVNVS R375
CK1D (rat) KVsMRLHRGAPVNVs R375
S382-p
rGAPVNIsssDLtGR
Upstream
0 45
Treatment
  • ischemia
  • SB202190
CK1D (human) rGAPVNIsssDLtGR S382-p
CK1D iso2 (human) RGAPVNISSSDLTGR S382
CK1D (mouse) rGAPVNVsssDLTGR S382-p
CK1D iso2 (mouse) RGAPVNVSSSDLTGR S382
CK1D (rat) RGAPVNVsSsDLTGR S382-p
S383-p
GAPVNIsssDLtGRQ
0 11
CK1D (human) GAPVNIsssDLtGRQ S383-p
CK1D iso2 (human) GAPVNISSSDLTGRQ S383
CK1D (mouse) GAPVNVsssDLTGRQ S383-p
CK1D iso2 (mouse) GAPVNVSSSDLTGRQ S383
CK1D (rat) GAPVNVsSsDLTGRQ S383
S384-p
APVNIsssDLtGRQD
0 16
CK1D (human) APVNIsssDLtGRQD S384-p
CK1D iso2 (human) APVNISSSDLTGRQD S384
CK1D (mouse) APVNVsssDLTGRQD S384-p
CK1D iso2 (mouse) APVNVSSSDLTGRQD S384
CK1D (rat) APVNVsSsDLTGRQD S384-p
T387-p
NIsssDLtGRQDTSR
0 3
CK1D (human) NIsssDLtGRQDTSR T387-p
CK1D iso2 (human) NISSSDLTGRQDTSR T387
CK1D (mouse) NVsssDLTGRQDTSR T387
CK1D iso2 (mouse) NVSSSDLTGRQDTSR T387
CK1D (rat) NVsSsDLTGRQDtsR T387
T392
DLtGRQDTSRMsTsQ
0 1
CK1D (human) DLtGRQDTSRMsTsQ T392
CK1D iso2 (human) DLTGRQDTSRMstsQ T392
CK1D (mouse) DLTGRQDTSRMsTSQ T392
CK1D iso2 (mouse) DLTGRQDTSRMstsQ T392
CK1D (rat) DLTGRQDtsRMstsQ T392-p
S393
LtGRQDTSRMsTsQI
0 1
CK1D (human) LtGRQDTSRMsTsQI S393
CK1D iso2 (human) LTGRQDTSRMstsQN S393
CK1D (mouse) LTGRQDTSRMsTSQI S393
CK1D iso2 (mouse) LTGRQDTSRMstsQN S393
CK1D (rat) LTGRQDtsRMstsQI S393-p
S396-p
RQDTSRMsTsQIPGR
0 9
CK1D (human) RQDTSRMsTsQIPGR S396-p
CK1D iso2 (human) RQDTSRMstsQNsIP S396-p
CK1D (mouse) RQDTSRMsTSQIPGR S396-p
CK1D iso2 (mouse) RQDTSRMstsQNsIP S396-p
CK1D (rat) RQDtsRMstsQIPGR S396-p
T397
QDTSRMsTsQIPGRV
1 9
CK1D (human) QDTSRMsTsQIPGRV T397
CK1D iso2 (human) QDTSRMstsQNsIPF T397-p
CK1D (mouse) QDTSRMsTSQIPGRV T397
CK1D iso2 (mouse) QDTSRMstsQNsIPF T397-p
CK1D (rat) QDtsRMstsQIPGRV T397-p
S398-p
DTSRMsTsQIPGRVA
0 11
CK1D (human) DTSRMsTsQIPGRVA S398-p
CK1D iso2 (human) DTSRMstsQNsIPFE S398-p
CK1D (mouse) DTSRMsTSQIPGRVA S398
CK1D iso2 (mouse) DTSRMstsQNsIPFE S398-p
CK1D (rat) DtsRMstsQIPGRVA S398-p
-
gap
0 19
CK1D (human) gap -
CK1D iso2 (human) RMstsQNsIPFEHHG S401-p
CK1D (mouse) gap -
CK1D iso2 (mouse) RMstsQNsIPFEHHG S401-p
CK1D (rat) gap -
S406-p
QIPGRVAssGLQsVV
0 3
CK1D (human) QIPGRVAssGLQsVV S406-p
CK1D iso2 (human) gap -
CK1D (mouse) QIPGRVASSGLQsVV S406
CK1D iso2 (mouse) gap -
CK1D (rat) QIPGRVASSGLQSVV S406
S407-p
IPGRVAssGLQsVVH
0 2
CK1D (human) IPGRVAssGLQsVVH S407-p
CK1D iso2 (human) gap -
CK1D (mouse) IPGRVASSGLQsVVH S407
CK1D iso2 (mouse) gap -
CK1D (rat) IPGRVASSGLQSVVH S407
S411-p
VAssGLQsVVHR___
0 2
CK1D (human) VAssGLQsVVHR___ S411-p
CK1D iso2 (human) gap -
CK1D (mouse) VASSGLQsVVHR___ S411-p
CK1D iso2 (mouse) gap -
CK1D (rat) VASSGLQSVVHR___ S411